Abstract
SMAUG1 is a human RNA-binding protein that is known to be dysregulated in a wide range of diseases. It is evolutionarily conserved and has been shown to form condensates containing translationally repressed RNAs. This indicates that condensation is central to proper SMAUG1 function; however, the factors governing condensation are largely unknown. In this work, we show that SMAUG1 drives the formation of liquid-like condensates in cells through its non-conventional C-terminal prion-like disordered region. We use biochemical assays to show that this liquid-liquid phase separation is independent of RNA binding and does not depend on other large, disordered regions that potentially harbor several binding sites for partner proteins. Using a combination of computational predictions, structural modeling, in vitro and in cell measurements, we also show that SMAUG1-driven condensation is negatively regulated by direct interactions with members of the 14-3-3 protein family. These interactions are mediated by four distinct phospho-regulated short linear motifs embedded in the disordered regions of SMAUG1, working synergistically. Interactions between SMAUG1 and 14-3-3 proteins drive the dissolution of condensates, alter the dynamics of the condensed state, and are likely to be intertwined with currently unknown regulatory mechanisms. Our results provide information on how SMAUG1 phase separation is regulated and the first known instance of 14-3-3 proteins being able to completely dissolve condensates by directly interacting with a phase separation driver, which might be a general mechanism in cells to regulate biological condensation.
Highlights
SMAUG1 is a human RNA-binding protein capable of condensation with unknown regulation
A prion-like domain of SMAUG1 drives condensation via liquid-liquid phase separation
SMAUG1 interacts with 14-3-3 proteins via four phospho-regulated short linear motifs
14-3-3 interactions change the dynamics of SMAUG1 condensates, promoting their dissolution
This is the first described regulatory mechanism for SMAUG1-driven condensation
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
Email addresses: John Fehilly john.fehilly{at}ucdconnect.ie, Olivia Carey 117348426{at}umail.ucc.ie, Eoghan O’Leary eoghan.oleary{at}targovax.com, Stephen O’Shea 117458944{at}umail.ucc.ie, Klaudia Juda klaudia.juda{at}merck.com, Rahel Fitzel rahel_fitzel{at}yahoo.de, Pooja Selvaraj poojaselvaraj.au{at}gmail.com, Andrew Lindsay a.lindsay{at}ucc.ie, Bálint Mészáros balint.meszaros{at}stjude.org
Abbreviations
- SAM
- sterile alpha motif
- SAMD4A
- SAM domain-containing protein 4A
- PHAT
- pseudo-HEAT analogous topology
- SSR
- SMAUG similarity region
- PLD
- prion-like domain
- IDR
- intrinsically disordered region
- LLPS
- liquid-liquid phase separation
- SG
- stress granule
- P-body
- processing body
- AMPK
- AMP-activated protein kinase
- mTOR
- mammalian target of rapamycin
- EDC4
- enhancer of mRNA-decapping protein 4 - UniProt
- G3BP1
- Ras-GTPase-activating binding protein 1
- GFP/EGFP
- green fluorescent protein/enhanced green fluorescent protein
- PBS
- phosphate buffered saline
- FRAP
- fluorescence recovery after photobleaching
- ANOVA
- analysis of variance
- DSSP
- define secondary structure of proteins
- SLiM
- short linear motif
- ELM
- Eukaryotic Linear Motif database